Breaking News

Financial Report: Abbott 3Q11

Pharmaceuticals sales up 14%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott 3Q11 3Q Revenues: $9.8 billion (+13%) 3Q Earnings: $303 million (-66%) YTD Revenues: $28.5 billion (+13%) YTD Earnings: $3.1 billion (+2%) Comments: Pharmaceuticals sales were up 14% in the quarter to $4.3 billion. Humira sales were up 26% to $2.1 billion. Kaletra sales were down 9% to $297.0 million. TRILIPIX/TriCor sales were up 2% to $419.0 million. Emerging markets sales were $2.6 billion, up 21%. Earnings in the quarter include a $1.5 billion pre-tax reserve for litigation relat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters